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Metal Interactions in Carcinogenesis:
Enhancement, Inhibition
by Gunnar F. Nordberg* and Ole Andersent
Metals constitute a fundamentally important part of the total human environment. Since
human exposure often involves complex mixtures of metal compounds and, possibly, organic
compounds which may be carcinogenic per se, interactions between these compounds may add
significantly to human cancer risk. Our present knowledge about these kinds of interactions is
very limited. The best investigated area is benzo(a)pyrene (BP)-metal oxide particle interactions
inrespiratory carcinogenesis inthe hamster. Metal oxide particles were also shown to modify the
carcinogenic effect of nitrosamines. Several reports describe experiments in which selenium
compounds exerted a generally anticarcinogenic and antimutagenic activity. Inorganic arsenic
compounds, which are accepted to be carcinogenic in man, have so far been negative in animal
experiments except for one recent suggested report. Several authors have, however, suggested
that these compounds may act as cocarcinogens due to their inhibition ofDNA repair, although
animal experiments to demonstrate a cocarcinogenic effect of arsenic compounds have been
negative sofar, exceptforonepreliminary report. The concentration ofzinc in the diet seemed to
influence both transplanted tumorgrowth andthe carcinogenicity ofseveral organic compounds,
and the possibility of a correlation between dietary zinc and certain cancer forms in man has
been suggested. Protection against development of Leydigiomas usually induced by cadmium
injection was afforded by simultaneous injection of zinc salts. Nickel carcinogenesis has been
reported to be antagonized by manganese, and synergism between Ni and organic carcinogens,
e.g. BP, has been demonstrated. There is no firm evidence that lead may be a cocarcinogen,
although some limited experimental evidence is available. Oxidizing agents have been demon-
strated to increase, and reducing agents to antagonize, the mutagenic effect of chromium
compounds in vitro. The content ofcarcinogenic and other metals in asbestos has been suggested
to modify the carcinogenic properties of asbestos. Since much of the information availabel at
present is suggestive, furtherresearch on these interactions as well as otherpossible interactions
in metal carcinogenesis is needed. Studies should be made both in well defined in vitro systems
and in relevant animal models.
Introduction
About 80 of the 104 identified members of the
periodical table ofthe elements are usually consid-
ered metals. Theycomprise afundamentaliyimpor-
tant part of our natural environment. Considerable
addition to natural human metal exposures may
occur both from work and from general environ-
mental pollution. Emissions from automobiles, from
combustion of coal and oil, as well as from mining
and other industrial activities contain complex
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mixtures ofmetals and some incompletely combusted
organic materials. Interactions between these com-
pounds may take place and increase the risk of
adverse health effects. In some populations ex-
posed to such complex mixtures, increased inci-
dence rates ofhuman cancer have been detected in
epidemiological studies. However, exposure to only
one agent has often been studied and statistically
correlated with increased incidence ofmalignancy.
In the general environment humans are always
exposed to complex mixtures of substances in
relatively low concentrations. The work environ-
ment is sometimes believed to present more clear-
cut exposures to single metal compounds. Howev-
er, this is probably more an exception than a rule,
and workers may be exposed to very complex
65mixtures of metallic compounds.
A good example of this is the environment at
some metal smelters and refineries. Workers inthis
environment have recently been shown to retain
increased lung burdens of a number of elements
such as As, Sb, Pb, Cd, Cr, Co, and La even
several years after retirement (1,2). An increased
incidence oflung cancer among such smelter work-
ers has been statistically associated with exposure
to arsenic (3). However, it cannot be excluded that
the other metals found may also be involved in
development of malignant lung disease (P. 0.
Wester, D. Brune, and G. F. Nordberg, Arsenic
and selenium in tissues of smelter workers in
relation to diagnosis, to be published). Interactions
among metals have previously been reviewed in
relationtononcarcinogenic effects (4) and in relation
to carcinogenesis (5,6). This review will focus on
the role ofmetals as factors enhancing or inhibiting
carcinogenesis and mutagenesis in experimental
systems in relation to experience from human
epidemiological studies and will try to identify
pertinent research needs.
Arsenic
Human exposures toinorganic arsenic compounds
have been associated with an increased incidence of
cancer. Occupational exposure in the smelting and
refining of copper ore and in the manufacturing of
arsenic containing insecticides has given rise to
lung cancer. The medicinal use of trivalent inor-
ganic arsenic compounds has been associated with
the development ofskin cancer. This forn ofcancer
is also more commonly found in populations ex-
posed to arsenic through drinking water. Angio-
sarcoma ofthe liver and malignancies oflymphatic
tissues have also been reported to be associated
with exposure to arsenic, but the evidence is not
conclusive.
Carcinogenic effects ofarsenic has recently been
reviewed (7,8).
Although human exposures to arsenic often in-
volve simultaneous exposure to a number of other
agents, interactions have not been clearly demon-
strated. A possible interaction with SO2 was exam-
ined by Lee and Fraumeni (9), who reported a
significant increase in lung cancer mortality among
arsenic exposed workers. When dividing the stud-
ied population according to exposure levels at
different working areas into heavy, medium and
lightexposure to arsenic, 6.7, 4.8, and 2.4 timesthe
expected mortality from respiratory cancer was
found. Workers were also exposed to SO2, and
similar division according to exposure to SO2 gave
6.0 to 2.6 times the mortality expected. Working
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areas with a heavy exposure to arsenic were also
medium S02-exposed, and heavy SO2 exposure
areas were medium arsenic-exposed. The authors
concluded that the worker with the highest risk of
respiratory cancer had a heavy exposure to arsenic
and a medium exposure to SO2. Pershagen et al. (3)
noted a significant increase in mortality (2-3 times)
from respiratory cancer in a population around a
metal smelter emitting arsenic and several other
metals. The increased mortality was no longer
significant when employees at the plant were ex-
cluded.
Chromosomal anomalies have been induced in
mammalian cells after arsenite and arsenate expo-
sure in vitro (10,11) and have been observed in
cultured human lymphocytes afterinvivo exposure
to arsenic compounds due to medical use (12,13) or
occupational exposure (14,15).
It was claimed (16) that arsenic compounds are
mutagenic in bacteria, but reinvestigation by oth-
ers (17,18) showedthatbothinbacteria (E. coli and
Salmonella) and mammalian cells (Chinese ham-
ster V79) arsenite was not mutagenic. Due to
inhibition of error-prone DNA repair, arsenite
lowered the rate of UV-induced mutations in E.
coli (19). It has been suggested that arsenic may
substitute for phosphorus in the phosphorylation of
nucleotides (12,13,20), although evidence for this
has not been presented. Jung et al. (21) found that
arsenic enhanced the UV sensitivity of human
epidermal fibroblasts. Several reports describe
inhibiting effects of arsenic on enzymes, especially
those containing SH-groups necessary for activity.
Beckman et al. (14) and Nordenson et al. (15),
who noted an excess ofchromosome aberrations in
workers exposed to arsenic, stressed that the
individual with the highest rate of aberrations had
alsobeen exposed to lead and selenium and thatthe
correlation between arsenic exposure and frequency
ofbreaks wasratherpoor. Theirdataalsoindicated
that arsenic exposure in combination with smoking
caused more breaks than smoking or arsenic expo-
sure alone.
Published animal experiments concerning carcino-
genesis ofarsenic compounds do notallow adefinite
conclusionthatarsenicisacarcinogeninexperimental
animals (7) in spite ofthefactthatthere is sufficient
epidemiological evidence to declare arsenic as a
carcinogen in man. In light of the previously
mentioned effects of arsenic on DNA-synthesis, it
is possible that arsenic is a cocarcinogen, inhibiting
repair of DNA lesions produced by other carcino-
gens. Some studies designed to examine this possi-
bility have been negative. Boutwell (22) found no
initiating effect of potassium arsenite followed by
croton oil in induction of skin cancer in mice.
Environmental Health PerspectivesPotassium arsenite was not cocarcinogenic after
DMBA[7,12-dimethylbenz(a)anthracene]application
in the same study. Initiation with DMBA followed
by promotion with croton oil was not influenced by
additionalapplication ofarsenite. Barone et al. (23),
testing the same substances, also concluded that
arsenate was not cocarcinogenic. Kroes et al. (24)
found no synergism between diethylnitrosamine
and arsenate with regard to tumors in rats.
When discussing possible interactions involving
arsenic, two recent preliminary studies are of
interest. Ishinishi et al. (25) reported that
intratracheal instillation ofarsenic trioxide, arsenic
containing copper ore, and flue dust from metal
refiningmight actascocarcinogens onbenzo(a)pyrene
(BP)-induced lung cancer in rats. Different groups
ofrats received 15 weekly intratracheal instillations
ofBP alone or in combination with copper ore, flue
dust, or pure As203. Control groups received the
same amounts ofcopper ore, flue dust, pure As203,
or the instillation vehicle, 0.9% NaCl. The groups
(7-10 rats/group) were too small to yield significant
differences: Numbers of malignant lung tumor
(squamouscellcarcinoma + adenocarcinoma)-bearing
animals were: 1/7 in the BP group (14.3%) and the
sum 8/27 in the three groups receiving BP plus
arsenic (ore/dust/As203) (29.6%). Adenocarcinoma
(1/7) was found in the group receiving flue dust
without BP, and in the other control groups no
malignant tumors were found. An evaluation ofthis
study is difficult because of the small number of
animals used in the various groups and, therefore,
an enhancement of BP-carcinogenesis by arsenic
cannot be regarded as established. Ivankovic et al.
(26) gave a single intratracheal instillation of cal-
cium arsenate together with copper sulfate and
calcium oxide. In 15 rats surviving the treatment,
nine lung tumors developed. Controls given saline
had no tumors.
Other studies suggest an inhibiting effect of
arseniccompounds intumorigenesis. Schrauzerand
Ishmael (27) found that arsenite (10 ppm in drink-
ing water) significantly reduced the incidence rate
ofspontaneous mammary cancer after 15 months in
virgin female C3H/St mice to 27% compared with
82% in controls, although tumor growth was
significantly enhanced. Arsenic-treated mice gained
15% less weight during the experiment than did
control mice and an unspecific effect related to food
consumption might have been of importance.
Kanisawa and Schroeder (28) fed mice on a diet
low in trace elements in an environment where
external metal contamination was avoided and
added different metal salts to the drinking water.
In a group given 5 ,ug/ml of arsenite, 11.9% of the
mice died with tumors compared to 34.5% in the
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control group. The largest part of the difference
was for benign tumors; for malignant tumors the
numbers were 10.6% forthecontrolgroupand 7.2%
for the arsenic-exposed group.
Milner (29) investigated the effect of arsenic
trioxide (0.01% in drinking water) on methylchol-
anthrene (MC)-induced cutaneous tumors in three
strains of mice. Application of 10% MC in paraffin
discs to shaven skin was used for tumor initiation.
Promotion was achieved by grafting to syngeneic
recipients after 2-3 weeks. In different sub-
experiments arsenic drinking water was given
eitherduringinitiation, duringpromotion orduring
both initiation and promotion for DBA and Balb/C
mice, but only during initiation and promotion for
CxC3H. CxC3H mice drank arsenic water during8
weeks, DBA mice during4 weeks, and Balb/C mice
during 2 weeks prior to MC treatment. Recipients
drank arsenic water only during 8 weeks of obser-
vation after grafting. In Balb/C mice arsenic had
neither cocarcinogenic nor anticarcinogenic effect,
but in CxC3H mice arsenic produced a significant
reduction in MC induced carcinogenesis. In DBA
mice anonsignificantincrease in carcinogenesis was
observed. The differences in arsenic treatment of
the different mouse strains makes it difficult to
evaluate this study.
For a long time arsenic has been known to
possess an antagonistic effect against generaltoxic-
ity and also against teratogenic effects ofselenium
and vice versa (30). No reports are found concern-
ing antagonistic effects between arsenic and sele-
niumwithregardtocarcinogenicityormutagenicity.
The possibility of such an effect, however, was
suggested byrecent studies ofmetalconcentrations
in lungs from smelter workers. Workers that died
with malignancies had higher As/Se ratios than
those from the same environment who died from
other causes. Concentrations of arsenic were the
same in these groups (Wester, unpublished).
Walker and Bradley (31) reported synergistic
effects of sodium arsenate and selenocysteine on
chromosomal crossing over in Drosophila melano-
gaster, which they tentatively ascribed to incorpo-
ration ofarsenate intoDNAand selenocysteineinto
chromosomal protein. Moutschen and Degraeve
(32) found synergistic effects between the organic
arsenical m-diamino-p-dioxyarsenobenzene methy-
lene sulfoxylic acid and ethyl methanesulfonate in
induction ofchromosome anomalies in barley. ,crkn
and Bencko (33) reported that arsenic significantly
increased the yield ofdominant lethal mutations in
F3 of mice after treatment with TEPA [tris (1-
aziridinyl) phosphine oxide] and suggested that the
enhancingeffect ofarsenicwas due toblockdngofSH-
groups in enzymes involved in DNA repair (34).
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In many cases human exposure to arsenic and its
compounds occurs in combination with other met-
als, SO2 or organic carcinogens. However, conclu-
sive evidence is not yet available concerning en-
hancing orantagonistic effects ofarsenic compounds
in combination with other metals or carcinogens.
One reason for the difficulties in studying interac-
tions involving the carcinogenic effects ofarsenic is
the absence ofasuitable animalmodel. Interestingly
two recent studies employing combinations of arse-
nic compounds and other substances furnish sug-
gestive evidence ofa carcinogenic effect in animals.
Since arseniccompoundsmightact ascocarcinogens,
further studies in vivo and in vitro with arsenic
compounds and other carcinogenic compounds in
combination should be carried out. In particular
combinations ofagents which occur in human expo-
sure situations should be examined. These include
combinations of arsenic compounds with BP, SO2,
selenium, cadmium, copper, zinc, lead, and several
other metals that occur in emissions from mining
operations, oil and coal burning.
Selenium
Selenium is an essential trace element, which is
highly toxic in higher concentrations. It was origi-
nally thought to be a carcinogen (35,36), but exten-
sive reinvestigation did not support this (37,38). A
review on carcinogenesis experiments with sele-
nium in animals has been given in an IARC
publication (39). Some evidence actually suggests
selenium to possess antitumorigenic activities:
Schrauzer and Ishmael (27) demonstrated that 2
ppm selenite in drinking water for 15 months
lowered the incidence of spontaneous mammary
cancers in female virgin C3H/St mice down to 10%
compared with 82% in controls. Selenium also
inhibited the growth rate ofspontaneous tumors. A
later report (40) described that ZnCl2 abolishes the
cancer-protecting effect ofselenite. Intumorinduc-
tion experiments with several organic carcinogens
dietary selenite significantly reduced the number of
tumors (Table 1).
In addition to the dietary experiments summa-
rized in Table 1, some nondietary experiments have
been reported. Shamberger and Rudolph (46) dem-
Table 1. Anticarcinogenic effects of selenium compounds.
Animal Carcinogen Selenium treatment Result Reference
Female OSU N-2-Fluorenyl acetamide, Selenite, 2.5 ppm 80% tumors (320 days) (41)
brown Rats 150 ppm in food in food
(20 per group) 0 100% tumors (320 days)
Male Sprague- 3-Methyl-4-dimethyl- Selenite, 6 ppm in 9/14 animals with liver tumors (12 weeks) (42)
Dawley rats aminoazobenzene, in food
0.05%, in food Selenite, 6 ppm 7/15 animals with liver tumors (12 weeks)
in water
0 11/12 animals with liver tumors (12 weeks)
Male Sprague- 1,2-Dimethyl hydra- Selenite, 4 ppm 6/15 animals with colon tumors (43)
Dawley rats zine, inj. 20 mg/kg, in water
1 x 18 weeks 0 13/15 animals with colon tumors
Male Sprague- Methylazoxymethanol Selenite, 4 ppm 14/15 animals with colon tumors (total 42 tumors) (43)
Dawley rats acetate, inj. 20 mg/kg, in water
1 x 18 weeks 0 14/14 animals with colon tumors (total 73 tumors)
Rats m-Methyl-p-dimethyl- Selenite, 5 ppm 7/15 animals with liver tumors (44)
(unspecified) aminoazobenzene, in food, 4 weeks
0.064%, 2 x 4 weeks, between weeks
in food with carcinogen
0 4/13 animals with liver tumors
Female albino DMBA-croton oil Selenite, 0.1 ppm 60% animals with tumors after 20 weeks (45)
ICR swiss (skin painting) Selenite, 0.1 ppm 78% animals with tumors after 20 weeks
mice (36 in food
animals per Selenite, 1.0 ppm 35% animals with tumors after 20 weeks
group) in food
0 72% animals with tumors after 20 weeks
Female albino Benzopyrene Selenite, 0.1 ppm 18/35 animals with tumors after 22 weeks (46)
ICR swiss (skin painting) Selenite, 0.1 ppm 26/36 animals with tumors after 22 weeks
mice (36 in food
animals Selenite, 1.0 ppm 16/36 animals with tumors after 22 weeks
per group) in food
0 31/36 animals with tumors after 22 weeks
68 Environmental Health Perspectivesonstrated that sodium selenide, when painted to-
getherwith croton oil on the skin ofmice which had
been initiated with dimethylbenzanthracene, re-
duced the total number of skin tumors observed
from 132 in 39 control animals only treated with
croton oil down to 9 in 30 animals treated with both
croton oil and selenide. This finding was confirmed
byRiley(47),usingthesamecompounds. Shamberger
(45) reported that selenide also decreased the
carcinogenic effect of3-methylcholanthrene in mice.
Both compounds were applied by skin painting.
Exon et al. (48) investigated the effect of dietary
selenium on tumor induction by the oncogenic
Rauscher leukemia virus, and found no protective
effect.
Several studies describe lower serum selenium
values in cancer patients than in persons not
sufferingfrom amalignant disease (49-52). Therapy
elevated serum selenium levels in cancer patients
(50). It cannot be concluded whether these effects
hadanyrelationshiptotheproposedanticarcinogenic
effects of selenium compounds.
It has been reported in demographic investiga-
tions that cancer mortality may be inversely re-
lated to bioavailability ofselenium (27,53-55); how-
ever, because ofseveral problems in these studies,
including difficulties in the geographical correlation
of Se intakes with cancer mortality, these studies
cannot be regarded as conclusive. In smelter work-
ers exposed to arsenic and other metals, tissue
selenium concentrations were lower in workers
dyingfrommalignancies (Wester, unpublished data)
compared with those dying from other causes.
Seleniumcompoundsareweakmutagensinbacteria
(56,57) and cause chromosome aberrations (56,58)
and elevated SCE (sister chromatic exchange) rate
in human cells (59). But some other reports de-
scribe antimutagenic effects ofseleniumcompounds
in vitro: selenite decreased the mutagenicity of
2-acetylaminofluorene, N-hydroxyaminofluorene, and
N-hydroxy-2-acetylaminofluorene in the Ames test
(60). Na2SeO3 significantly lowered the chromo-
some breakage in human lymphocytes treated in
vitro with DMBA (61).
Conclusions on Selenium
Possible carcinogenic properties of selenium are
not completely ruled out, especially since selenium
compounds have been shown to be weakly muta-
genic in bacteria and cause chromosome anomalies
in mammalian cells. Several reports describe
antitumorigenic activity ofseleniumin experimental
animals. Human data are presently inconclusive,
but suggest the possibility of an anticarcinogenic
effect ofhigh dietary selenium. Further research is
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needed, employing adequate epidemiological meth-
ods in population groups exposed to carcinogens.
Experiments with known mutagenic metals and
selenium in combination should be carried out both
in vitro and in animal models. Further studies of
the role of dietary selenium at concentrations
relevant for the human situation would also be of
value.
Zinc
Zinc is an essential trace element. It is incorpo-
rated into several metalloenzymes and is necessary
for DNA, RNA, and protein synthesis in mamma-
lian cells. Zinc accelerates wound healing, is in-
volved in membrane stabilization, and is mitogenic
toT-lymphocytes. Zincdeficiencyleadstoimpairment
of cell mediated immunity. In animal experiments,
the only carcinogenic effect of zinc reported is
induction of testes tumors after intratesticular
injection (62). There are no indications that occupa-
tional exposure to zinc leads to increased cancer
risk. Zinc protects experimental animals against
the necrotizing activity in the testes, of injected
cadmium, and also against cadmium induced
Leydigioma after total testes atrophy. This will be
discussed in detail in the section about cadmium.
In the following, experiments investigating the
effect of dietary zinc supplementation on tumor
growth and chemical carcinogenesis will be re-
viewed.
Petering et al. (63) investigated the effect of
dietary zinc on the growth of Walker 256 carcino-
sarcoma in the rat and found a linear positive
relationship between tumor growth and dietary
zinc between 40 and 640 jig zinc/day per animal.
This has been confirmed by several other groups.
The experiments are summarized in Table 2. In
these experiments, the control groups of rats or
mice received either 50-80 ,ug/gzinc in the food or a
zinc-free diet and 50-60 jig/ml zinc in water. This is
more than the amount needed for optimal growth.
Several reports describe that dietary zinc
restriction decreases the growth of a range of
transplanted tumors in rats and mice (Table 2).
Barr and Harris (68) grew the P 388 leukemia as
an ascites tumor in male DBA/2 mice fed a zinc-
deficient diet(0.8ppmzinc). Theyfound asignificant
reduction in tumor cell growth when animals were
given zinc-free water compared with animals given
water containing 670 ppm zinc. Since a zinc-
adequate group was not included, evaluation ofthis
study is difficult.
Intraperitoneal injection of 3 x 0.5 mg zinc
acetate at 1, 3, and 5 days after IP injection of
L1210 leukemia cells into BDF mice reduced the
69mortality due to tumor development from 100% in
the control group notreceiving zinc injections down
to 30%. In a similar experiment, where BW5147
lymphatic leukemia cells were injected into AKR/J
mice, repeated zinc injections gave only a marginal
increase in survival time without affecting the
mortality (69).
A single report describes that very high dietary
zinc inhibits transplanted tumor growth (Table 2).
The effect ofdietary zinc supplementation on chem-
ical carcinogenesis has been investigated in several
reports with anumberofchemical carcinogens. The
experiments are summarized in Table 3.
Epidemiological evidence relating to the role of
zinc in carcinogenesis is very limited and difficult to
interpret. In some reports concerningdemographic
data, it has been suggested that high dietary zinc
mayincreasetheincidence ofgastric cancer(76,77).
Schrauzer et al. (78) used data from their own
studies and from those of Kubota et al. (79) and
calculated correlation coefficients between concen-
trations of zinc in whole blood and female breast
cancermortalities in several states and major cities
in the U.S. In these studies the authors claimed to
have found an association between high zinc intake
or high blood zinc and a high incidence of breast
cancer. However, thesemacroepidemiological stud-
ies suffer from the weaknesses usually encountered
in such studies. The difficulties in obtaining a true
geographical congruence between the zinc data and
the mortality data should be appreciated as well as
the difficulties in finding appropriate mathematical-
statistical means of treating the data which were
not collected particularly for the purpose of this
study (78). It maywellbe thatdietary zinc intake is
of importance for the development of human can-
Table 2. Effect ofdietary zinc on transplanted tumor growth in relation to control animals given "normal" zinc (not shown).
Animal Dietary zinc status Transplanted tumor type Resulta Reference
Female Wistar rats 500 mg/g food Hepatoma induced by 3'-methyl- i (64)
0.4 ,ug/g food 4-dimethylaminoazobenzene i
Male Sprague- Zinc-free Walker 256 carcinosarcoma i (65)
Dawley rats 500 Fg/g water
Male Sprague- Zinc-free Walker 256 carcinosarcoma i (66)
Dawley rats
Male CDF mice Zinc-free L5178yt leukemia i (67)
L1210 leukemia (i)
P388 leukemia
Male C57BL/6 Zinc-free Lewis lung carcinoma i (67)
a = inhibition; - = not statistically different from control.
Table 3. Effect ofdietary zinc on local chemical carcinogenesis in relation to controls with "normal" zinc intake (not shown).
Dietary zinc
Animal status Carcinogen Application Resulta Reference
Male Charles 7 Rg/g food Methylbenzylnitrosamine Gavage (esophagus) e (70)
River rats
Female Swiss 0.4 ,g/g food 3-Methylcholanthracene Skin painting i (71)
mice > 500 ,g/g food i




Syrian golden 21.9 Rg/g zinc Dimethylbenzanthracene Painting of cheek pouch i (73)
hamsters in food + 100
Rg/g zinc in
waterc
Syrian golden 22.1 ,g/g zinc Dimethylbenzanthracene Painting of cheek pouch i (74)
hamsters in food + 100
,ug/g in waterc
Wistar rats 250 ,ug/g water Dimethylbenzanthracene Implant in submandibular gland r (75)
a Results: e = enhancement i = inhibition; a = acceleration; r = retardation.
b Drinking water contained 0.1 FM zinc.
c Control animals received the same amount of zinc in food + zinc-free water.
Environmental Health Perspectives 70cer, but presently available data can by no means
be regarded as conclusive evidence.
Conclusions on Zinc
Dietary zinc deficiency inthe rat (7 ,ug/gorlessin
the diet) leads to suppression oftransplanted tumor
growth and possibly to reduced chemical carcino-
genesis. Dietary zinc supplementation (> 200 ,uglg)
leads to equivocal changes in transplanted tumor
growth and in carcinogenic response. The significance
ofhigher or lower dietary zinc in relation to human
cancer remains unresolved. Injected zinc offers
protection against cadmium-induced testicular tu-
mors in mice and rats. Further epidemiological
research concerning the role of dietary zinc in
carcinogenesis is recommended, since the human
dietary zinc intake shows great variations. Further
animal studies including marginally adequate zinc
intakes would be of interest since most of the
animal experiments reported so far used control
concentrations higher than necessary.
Such studies should always include untreated
control groups given the same dietary zinc concen-
trations as carcinogen-treated animals, and the
serum and liver concentrations of zinc and also of




in animal experiments. Occupational exposure to
nickel compounds have led to nasal, laryngeal and
lung cancer in humans. Reviews on nickel carcino-
genesis have been published by Sunderman (62,80)
and the National Academy of Sciences (81). The
carcinogenic properties of nickel compounds were
recognized many years ago, and a considerable
amount ofinformation including experimental work
concerning nickel carcinogenesis is available also in
relation to other compounds.
Maenza et al. (82) observed a synergistic action
between Ni3S2 and BP after im application, since
thetimelagforinductionofsarcomaswassignificantly
shortened by simultaneous application ofboth car-
cinogens, a result which could not be obtained by
increasing the dose of one of the carcinogens in
single applications. They injected either 10 mg of
Ni3S2, 5 mgofBP, orboth, deep into both thighs of
the rats. These (high) doses caused sarcomas in all
animals in all groups, but the mean latency time
before initial palpation oftumors was 18 ± 3 weeks
for the group receiving both carcinogens compared
with 26 ± 5 weeks for the group receiving Ni3S2,
and 31 ± 10weeks forthe groupreceiving BP. Also
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the mean survival time was significantly lowered in
the group receiving both carcinogens.
Kasprzak et al. (83) found increased incidence of
premalignant changes in lungs of rats receiving
intratracheal injections with a mixture of BP and
Ni3S2 compared with groups receiving one carcin-
ogen at a time: 0 of 13 animals receiving 5 mg of
Ni3S2 developed bronchial squamous metaplasia,
which was found in4 of13 animalsreceiving2 mgof
BP and in 8 of 13 animals receiving both 5 mg of
Ni3S2 and 2 mg of BP. Evaluation took place after
15 months. Toda (84) found that NiO increased the
incidence of lung tumors in rats induced by
20-methylcholanthrene.
The synergistic effect reported between organic
carcinogens and Ni-compounds has been suggested
to be related to the inhibitory effect of Ni com-
pounds onlungand livermicrosomalmixed function
oxygenase systems, which was shown with nickel
carbonyl by Sunderman (85,86). The activity of
BP-hydroxylase in vitro was notinhibited by nickel
carbonyl (81). It was suggested by Sunderman (85)
thatthe synergism between nickel and BP is due to
slower metabolism of BP and longer tissue reten-
tion of BP when nickel is present. This received
experimental support by the findings ofSunderman
and Roszel (87) that exposure to nickel carbonyl
inhibited mobilization from lung and liver of BP in
rats after IV injection of BP. The inhibition lasted
48 hr.
Nickel carbonyl also inhibits rat hepatic nuclear
RNA polymerase activity both in vivo and in vitro
(88,89), furnishing a possible explanation for the
inhibitory effect ofnickel on BP hydroxylase induc-
tion observed in vivo.
Manganese was shown to antagonize the tumori-
genic effect of Ni3S2 (90,91). Aluminum, copper,
and chromiumhad no effect inthesameexperimental
set up (90). Rats were given single im injections of
2.5 mg of Ni3S2 alone or in combination with metal
dust. When 2.1 mg of manganese dust was given
with Ni3S2, 15/24 rats developed sarcomas at the
injection site, compared with the control group,
receiving only Ni3S2, where 39/40 rats developed
sarcomas. Observationtimewas2years. Sunderman
et al. (91) showed that neither the excretion of Ni
nor the retention at the injection site were altered
by Mn, while the concentration of '3Ni in superna-
tants from ultracentrifugations of homogenates of
injection siteswas 5.8 + 0.7 (SD) ng/ml20-24 weeks
after injection of 1.2 mg of 63Ni3S2 and 2.0 mg of
Mn dust compared with 8.4 ± 3.2 (SD) ng/ml in
animals receiving 1.2 mg of 'Ni3S2 alone. In vitro
experints showed that the solubility of Ni was
significantly lowered in serum and water by Mno.
Sunderman (90) suggested that Mnantagonized the
71inhibition effect ofNi on RNA polymerase. Invitro
Mn° has also been shown to antagonize the effect of
Ni3S2, since transformation ofSyrian hamster fetal
cells by Ni3S2 could be almost totally inhibited by
addition of Mn dust (92).
There are some indications from epidemiological
studies (93,94) that tobacco smoking may be syner-
gistic to nickel compounds in induction of lung
cancer, as was suggested by Doll et al. (95). See
also (78). Animal experiments in hamsters with life
time exposure to NiO and cigarette smoke did not
confirm this (96).
Conclusions on Nickel
Nickel compounds are strong human and experi-
mental carcinogens. Synergism between the envi-
ronmentalcarcinogen BPand nickelin experimental
tumor induction has been documented. Synergism
between nickel exposure and cigarette smoking in
man has been suggested but not confirmed in
animal experiments.
Manganese antagonizes muscletumorigenesis and
in vitro transformation induced by Ni3S2. Further
research on the combined effect of nickel com-
pounds and especially other metals or carcinogens
(e.g., cadmium, hexavalent chromium and BP)
found together with nickel in industrial exposure
should be carried out.
Lead
Epidemiological investigations give no conclusive
evidence that lead is a human carcinogen (7,97,98).
Renal adenomas and carcinomas could regularly be
induced in animals by soluble lead salts after
different routes of application. Reviews of animal
experiments with lead-induced cancer has been
published by Sunderman (62) and IARC (7). The
latter reference also includes data on mutagenesis.
ThedatabyCooperandGaffey(99), partlyreanalyzed
by Kang et al. (100), indicated increased mortality
from malignant neoplasms of the digestive organs
and respiratory system in lead-exposed workers in
the USA. Cooper (101) stressed that these workers
had also been exposed to many other substances
and concluded that lead cannot be ruled out as a
cocarcinogen.
Kobayashi and Okamoto (102) suggested a
cocarcinogenic effect of PbO on BP-induced lung
tumors in hamsters after repeated intratracheal
instillations since the incidence of premalignant
metaplasias was increased in animals receiving
both PbO and BP compared with groups receiving
eithercompound alone. Groups of30hamsters were
given 10 weekly intratracheal instillations; one
group given 1 mg PbO had some metaplastic
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changes in alveoli, another group given 1 mg BP
also had metaplasia but no tumors. A third group
given both substances had 9 adenomas and 1
adenocarcinoma. In groups given the vehicle (0.5%
carboxymethylcellulose in 0.9% NaCl) or left
untreated no pathological lesions were found. The
time of observation was 60 weeks.
Beekand Obe (103) found noeffect oflead acetate
on x-ray-induced chromosome breaks in human
lymphocytes in vitro, but Skreb and Habazin-Novak
(104) found thatthe rate of3H-thymidine uptake by
HeLa cells is inhibited both by UV irradiation and
by addition of lead chloride in single application,
and that the effects ofirradiation and lead chloride
were additive in combined application, suggesting
that lead ions may affect DNA repair.
Whether lead exposure alone can cause severe
chromosome aberrations in man is still questioned.
The conflicting results present up to 1977 were
cited by Deknudt et al. (105). Several cytogenetic
studies of lead-exposed workers did not show an
increased rate ofchromosome aberrations (106-108).
Also, in vitro exposure ofhuman cells and Chinese
hamster cells to lead salts failed toyield an increase
in chromosome anomalies (108,109).
In some other studies in which combined expo-
sure to lead and other metals occurred increased
ratesofchromosomeanomalieswerefound:Deknudt
and collaborators (110,111) found an increased inci-
dence of chromosomal aberrations among workers
exposed to high concentrations of both lead and
cadmium. Bauchinger et al. (112) also investigated
workers exposed to both lead and cadmium and
suggested that these two heavy metals might act
synergistically to each other in inducing chromo-
some anomalies. Nordenson et al. (113) investi-
gated lead exposed workers from the Ronnskar
smelter. A characteristic feature of this working
place is that a number of different potentially
hazardous agents are present. Thus, the positive
findings ofNordenson et al. (113) might be due to a
combined exposure. Deknudt et al. (105) exposed
Cynomolgus monkeys to lead in drinking water.
Two monkeys kept on a diet low in calcium had
significantly more chromosome anomalies than two
monkeys kept on a calcium-sufficient diet. This
finding is in accord with the fact that a low calcium
diet increases the gastrointestinal absorption of
lead. It is likely that other factors that increase
gastrointestinal absorption ofPb, i.e., deficiency of
Fe, Vitamin D (114) could alsoincrease the chromo-
some breaking effect of lead.
Conclusions on Lead
There is no firm evidence that lead compounds
are carcinogenic or cocarcinogenic in man. Consis-
Environmental Health Perspectivestent data regarding the effect of lead on the
carcinogenic effects ofothermetals and carcinogens
are lacking. Due to the heavy environmental pollu-
tion with lead which is taking place, further exper-
imentsinvestigatingcarcinogenic (orcocarcinogenic)
effects of inorganic and organic lead compounds
particularly in combination with other agents de-
serve high priority. Further epidemiological inves-
tigations are needed concerning cancer incidence in
populations exposed to lead in combination with
other agents.
Chromium
Epidemiological investigations indicate that some
chromium compounds are carcinogenic for humans,
lung cancer having been found in excess among
workers in the chromate producing and utilizing
industry.
A few recent epidemiological investigations asso-
ciate chromium exposure with anincreaseingastric
cancer(115). In animal experiments, local sarcomas
were induced in different species after several
routes ofapplication ofchromium compounds. Sev-
eral reviews on chromium carcinogenesis are avail-
able (7,62,115-117). Many experiments indicate that
the mutagenic and, most likely, also carcinogenic
properties of chromium are exerted by hexavalent
compounds; reports that describe the effect of
changing the oxidation state of chromium are of
special interest in this context. Hexavalent chro-
mium ions can easily pass the cell and nuclear
membrane, but trivalent chromium ions cannot.
Thus, intracellular reduction captures Cr(III) in-
side the cell.
Tsudaand Kato (118,119) treated Syrian hamster
embryo cells growing in vitro with K2Cr2O7. At
0.5 ,ug/ml, a significant increase in chromosomal
aberrations was found (33% abnormal metaphases),
compared with untreated cultures (34% abnormal
metaphases). When 0.645 pug/ml of Na2SO3 was
added together with 0.5 jig/ml ofK2Cr2O7, the rate
of chromosome anomalies returned to nearly nor-
mal values (6% abnormal metaphases). Petriuli and
DeFlora(120) demonstrated that severalhexavalent
chromium compounds were active mutagens when
evaluated by the Ames test. By using several
mutants deficient in repair, they obtained evidence
that chromate induces both frame shifts and base
pair substitutions in Salmonella DNA. Addition of
S9-mix completely destroyed the mutagenic activ-
ity ofchromate, ifenough S9 was added. This is in
agreement with the report by Gruber andJennette
(121) that rat liver microsomes reduce hexavalent
chromium invitro. Mutagenicity disappeared when
several reducing agents were included in the assay
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mix in the studies ofPetrilli and DeFlora (122). The
reducing effect could be abolished by KMnO4 which
restored the mutagenic effect of hexavalent chro-
mium abolished by liver microsomes. Also human
erythrocyte lysate reduced the mutagenicity of
hexavalent chromium. Petrilli and DeFlora (122)
also demonstrated that trivalent chromium applied
alone was inefficient as amutageninthe Amestest,
butthatthe addition ofthe oxidizingagent KMnO4,
which was inactive when applied alone, gave rise to
a high reversion rate.
These studies do agree well with the report by
Nakamuro et al. (123). Trivalent chromium com-
pounds were found to be weak inducers ofchromo-
somal aberrations in human lymphocytes in vitro,
and to be weakly mutagenic in the rec-assay with
E. coli Hs3OR, while hexavalent chromium com-
pounds were strongly active in inducing chromo-
some anomalies and mutations. The effects of
hexavalent impurities in the trivalent chromium
compounds used in the studies mentioned may
account forthe slightmutagenic effect observed. In
fact, Petrilli and DeFlora (122) demonstrated that
the addition ofascorbic acid to an industrial sample
of chromite, which was weakly mutagenic reduced
this mutagenicity.
Lane and Mass (124) tested chromium carbonyl
(CC) as a carcinogen and as a cocarcinogen with
BP. Tracheal grafts implanted subcutaneously on
syngeneic rats wereifiled, eitherwith 2.5 mgofCC
in agar, with 2.5 mg of BP, or with both carcino-
gens. Control grafts received the vehicle agar
alone. BPyielded eightsquamous cellcarcinomasin
22 grafts, CC yielded two carcinomas in 22 grafts,
but BP+CC gave ten neoplasms, of which three
metastasized within 9 months in 24 grafts. The
authors suggested that CC might act as a
cocarcinogen with BP.
Conclusion on Chromium
Since hexavalent chromium is accepted as the
mutagenic and carcinogenic form of chromium and
since oxidative/reductive processes involving other
compounds have been demonstrated in vitro to
control the mutagenic effect ofchromium, there is
need for further studies ofthe metabolic activation/
deactivation of chromium compounds in whole ani-
mals: In man, exposure to hexavalent chromium
compounds has been reported only to induce lung
cancer, and possiblygastric cancer. The most likely
explanation as to why cancer does not occur at
other sites is the reduction ofhex-avalent chromium
to the trivalent state immediately after absorption.
In animal experiments hexavalent chromium com-
pounds induce local sarcomas.
73Cadmium
Some cadmium compounds are probably carcino-
genic in man following occupational exposure (7) as
respiratory and prostatic cancer have been found in
excess frequency among cadmium workers. The
carcinogenic properties ofcadmiumcompounds have
also found some support in animal experiments
where local sarcomata at the site of injection and
remote tumors in the testes have been demonstrat-
ed. A detailed review ofthe role ofcadmium in the
etiology of prostatic cancer is given by Piscator
(125).
Although combined exposures to cadmium and
other agents as in tobacco smoking or occurring
simultaneously in situations of occupational expo-
sure are very common, only the influence of simul-
taneous zinc exposure has been demonstrated.
Gunn et al. (126,127) reported that a combined
treatment with Zn gave a lower incidence of
Cd-induced testicular tumors (Leydigomas) in Wistar
rats and albino mice. A single subcutaneous injec-
tion of CdCl2 (0.03 mmole/kg) was given and after
10 months, 21 out of 25 rats (88%) had tumors. In
another group, a total of3 mmole/kg of Zn acetate
was given by injection in addition to the same
subcutaneous Cd dose as inthe first group, but only
2/17 developed testicular tumors. An effect of the
zinc treatment on the incidence of pleomorphic
sarcomas at the site of Cd-injections was reported
as well: 9/22 Cd-injected rats had such tumors but
only 2/17 Cd + Zn-injected and 0/18 in the control-
group. In another experiment 20/26 mice given 0.03
mmole/kg of Cd developed tumors after 14 months
but 0/25 mice, given 3.0 mmole/kg ofZn in addition
to the Cd, developed tumors. It was further dem-
onstrated that the content of ICSH-stimulating
hormone in the pituitary was higher in Cd-treated
animals than in the control group, showing that the
interstitial cells of the testis were not functioning
normally in these animals although they regener-
ated after initial damage immediately following a
Cd injection. A hormonal mechanism of Leydigoma-
induction was thus indicated and the zinc treatment
probably interfered with this inductional mecha-
nism. There are also other agents in addition to
zinc, which protect the testicles of experimental
animals against the necrotizing action of injected
cadmium, i.e. selenium (128,129) and cobaltous
chloride (130) or even pretreatment with a smaller
dose of cadmium itself (131-133).
Deknudt and Leonard (110) found a higher fre-
quency ofsevere chromosome anomalies inworkers
exposed to a combination of lead and cadmium
compared with workers exposed mainly to zinc (but
with alow exposuretoleadandcadmium). Bauchinger
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et al. (112) found an increased number of chromo-
some aberrations in workers exposed to lead,
cadmiumand zinc compared withthe controlgroup.
O'Riordan et al. (134) foundno statistically significant
increase in the number ofchromosome aberrations
in 40 men exposed to cadmium only (in the form of
Cd pigments) and speculated that effects reported
by other authors might be due to combined effects
of Cd and other metals.
Unger and Clausen (135) demonstrated that
injected cadmium salt gave rise to a diminished
P-450 activity in the liver ofmice. This effect does
not occurinlong-term repeated exposuredue tothe
protective effect of induced metallothionein (136)
and, although an effect of cadmium on mixed-
function oxygenase would be ofinterest in relation
to the carcinogenicity ofmany organic compounds,
the fact that it occurs only in acute exposures
makes it of limited practical importance with re-
gard to the situation in liver tissue.
Conclusions on Cadmium
Exposure to cadmium compounds has been shown
tocontribute tothe development ofprostatic cancer
in workers exposed to high concentrations. In
animals injection of cadmium compounds give rise
to testicular atrophy and subsequent development
of Leydig cell tumors. These effects can be pre-
vented by injection of large doses of zinc. It has
been demonstrated in animals that hormonal fac-
tors are of importance for the development of the
Leydig cell tumors. Hormonal factors may well be
of importance also in the case of human prostatic
cancer and factors influencing the male sex hor-
mones may deserve further study.
Further research on possible interactions be-
tween cadmium and e.g. BP, arsenic and selenium
would be ofinterest. In exposure atwork, cadmium
is found together with nickel, zinc, copper, and
lead. Combination experimentsinvolvingthese met-
als and their compounds are needed.
Metal Interactions in BP,
Nitrosamine, and Asbestos
Carcinogenesis
BP and other PAH (polycyclic aromatic hydro-
carbons) present in oil products or produced by
incomplete combustion oforganic material are con-
sidered as potent human carcinogens partially re-
sponsible for the increase in lung cancer observed.
Saffiotti et al. (137) reviewed evidence that BP
(whichafterskinapplicationleadstoskintumors)is
only weakly carcinogenic in the respiratory system
Environmental Health Perspectivesofthe hamster afterintratracheal instillation. They
presented experimental evidence that BP is a
strong respiratory carcinogen when administered
in combination with Fe2O3 in mixtures prepared by
grinding. Feron (138) and Feron et al. (139) showed
that high doses of BP and long observation times
are required (36 x 1 mg/week or more) to obtain a
high tumor yield. The carcinogenic effect of BP-
Fe203mixtures wasfurtherinvestigated by Saffiotti
et al. (140,141), who examined the response after
different dose levels and different number of
instillations. When hamsters were given 30 weekly
instillations of 1:1 mixtures of BP and Fe2O3 in
0.9% NaCl at doses of 0.25, 0.50, 1.0, and 2.0
mg/week of each compound, a correlation between
dose and response could be seen. In other experi-
ments the tumor incidence was compared among
groups of animals receiving the same total dose in
one instillation or several instillations. The effect of
dose fractionation was evident. When 3 mg of BP
was given with 3 mg ofFe2O3 weekly for 5, 10, and
15 weeks, a clear effect ofrepeated instillation was
found: The group receiving 15 instillations had 105
respiratory tract tumors in 94 animals, the group
receiving 10 instillations had 53 respiratory tumors
in 121 animals, andthe groupreceiving5instillations
had 20 respiratory tumors. A group of animals
receiving onesingleinstillationof37.5 mgBP + 12.5
mg Fe2O3 had 10 respiratory tumors in 60 animals.
In these studies control animals received either
Fe2O3 at different doses and number ofinstillations
or were instilled with 0.9% NaCl. No respiratory
tract tumors were found in control animals.
In a later study by Henry et al. (142) a control
group receiving only BP was included. Syrian
golden hamsters were given 30 weekly instillations
in gelatin (total dose of BP 26.1-27.4 mg). In one
group given BP-Fe2O3 prepared by low tempera-
ture precipitation of BP on Fe2O3, 73% developed
tumors. BP-Fe2O3 prepared by grinding yielded
84% tumor-bearing animals. In group 3, given
BP-Fe2O3 prepared by mixing together the two
components in the instillation vehicle (gelatin), 12%
developed tumors. In group 4, receiving BP alone
in gelatin, 17% had tumors. Group 5, receiving
gelatin alone, had no tumors. Development of
tumors was much faster in groups receiving Fe2O3
and BP prepared by grinding or low temperature
precipitation than in groups receiving BP alone or
mixed with Fe2O3, demonstrating further the im-
portance of the physical properties of metal
oxide-BP-mixtures.
As had been noted in studies by Saffiotti and
co-workers (143) the lung clearance ofBP is depen-
dent on the character of the instillation mixture.
BP-Fe2O3 mixtures prepared by grinding were
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cleared much more slowly than BP instilled alone,
or mixed with Fe2O3 without physical attachment.
Stenback et al. (144,145) compared other metal
oxides with Fe2O3 as carrier dust in BP-induced
lung carcinogenesis in Syrian golden hamsters.
They found that MgO was as effective as Fe2O3. In
a group receiving 20 weekly instillations of2 mg of
BP + 1 mg of MgO there were 72% respiratory
cancer-bearing animals. In a group receiving 15
weekly instillations of3 mgofBP + 3 mg ofFe2O3,
70% tumor-bearing animals were found.
In another experiment, different groups of ani-
mals received 15 weekly instillations of TiO2,
A1203, carbon, or Fe2O3, alone or in combination
with BP. One groupreceived BPand one groupwas
untreated. The authors do not state howlarge were
the doses that the individual groups received.
Evaluation ofthe results is therefore difficult. The
authors concluded that A1203 and carbon are
inefficient as carrier dusts, but that TiO2 is as
efficient as Fe2O3. BP alone yielded few respiratory
tumors.
Montesano et al. (146) found a modifying effect of
Fe2O3 on DEN (diethylnitrosamine) carcinogenesis.
A group ofhamsters received a total dose of30 mg
of BP + 30 mg of Fe2O3 in 15 instillations every
second week, followed by a total dose of 12 mg
DEN administered subcutaneously in 12 weekly
injections. Other groups received the same dose of
BP + Fe2O3 without DEN, and the same dose of
DEN without BP + Fe2O3. One group received 30
mg of Fe2O3 without BP, and 12 mg of DEN. All
groups receiving DEN showed a high yield oftotal
tumors not significantly different between groups.
ThegroupreceivingBP + Fe2O3hadlessthan 1/3of
the tumor yield observed in other groups. The
authors concluded that BP-Fe2O3 acted syner-
gisticallywith DEN, since the group receivingboth
carcinogenic treatments developed many tumors
below the nasal cavity. In that group, the rate of
squamous cell carcinomas of the tracheobronchial
tract was 31% compared with 0% in the 3 other
groups.
Thelatencytimeforthedevelopmentofrespiratory
tract tumors excluding nasal cavity was much
shorter when animals received both DEN and
BP-Fe2O3, suggesting a synergistic effect.
The group receiving DEN and Fe2O3 yielded
slightly more tumors than the group receiving only
DEN, suggesting an enhancing effect. Stenback et
al. (147) also noted an enhancing effect when 12
weekly SC injections of 1 mg of DEN were com-
bined with intratracheal instillations of different
dusts. Although the total tumor yield did not vary
between the groups, a high yield of lung tumors
wasonlyobservedinanimalsreceivingintratracheal
75instillations. The dusts used were MgO, A1203, and
carbon. In all groups the instillation vehicle was
0.9% NaCl. In the group receiving DEN but no
instillations, only one lung tumor was observed. In
groups receiving dust instillations without DEN,
no lung tumors were seen. In a group receiving
DEN andinstillations of0.9% NaCl, the lungtumor
yield was as high as in the groups receiving dust;
the question is whether a mechanical effect of the
instillation process influences DEN carcinogenesis.
Nettesheim et al. (148) noted an enhancingeffect
of Fe2O3 on DEN induced lung carcinogenesis.
They gave groups of hamsters 12 weekly SC
injections of 0.25 mg of DEN and exposed the
different groups to different inhalation schedules
for life time. In 131 animals receiving only DEN
were found 18 nasal, 140 larynx plus trachea, and
17 lung plus bronical tumors (175 in total). In 133
animals receiving DEN plus Fe2O3, 40 mg/m3
during 6 hr, 5 days/week there were 6 nasal, 114
larynx plus trachea, and 46 lung plus bronchial
tumors (166 in total). In 132 animals exposed to
Fe2O3 alone, no respiratory tract tumors were
found. Although the total tumor yield did not vary
much, the localization of tumors was significantly
different. The latency time, both for development
oflungtumors and fordeaths from lungtumors due
to DEN-application, was shortened significantly by
Fe2O3 exposure.
Studies in the rat demonstrated that metal ions
enhanced the carcinogenic and toxic action ofENU
(N-ethyl-N-nitrosourea) (149,150). CuS04, NiSO4,
and especially CoCl2 increased the tumor yield
after SC injection of ENU. Also FeCl2 and MnCl2
increased the number of local sarcomas and de-
creased the latency time for tumor induction when
compared with animals receiving ENU alone (151).
On the other hand, CuS04 and CoCl2 did not
influence carcinogenesis induced by DEN in rats
(152).
The present belief is that the carcinogenicity of
asbestos fibers is closely related to fiber structure
and size. This will not be further discussed in this
text. However, asbestos fibers may be a carrier
dust for other carcinogens, e.g., metals and BP.
Severalinvestigationshaveshownthatsmallamounts
of metals are-associated with asbestos fibers, both
in elementary form and as salts, especially those of
nickel, chromium, manganese and iron. Smaller
amounts of vanadium, zinc, copper and cobalt may
be found.
Cralley (153) suggested that electromotive prop-
erties of metals in asbestos fibers might influence
the carcinogenic properties. Especially the content
ofnickel and manganese was discussed. He argued
that the standard reduction potentials for the
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individual metals associated with asbestos fibers
determined both the rate and order in which the
metals would be solubilized inionicform, and which
electrolytes would be reduced to elementary met-
als, and suggested that this may modify asbestos
carcinogenesis. Since relationships between carcino-
genicity and tissue concentration of specific metal
species are not completely known it is difficult to
evaluate the plausibility ofthese theories concern-
ing the role of metals in asbestos carcinogenicity.
Thomson et al. (154,155) investigated the effect
ofasbestos-associated metalions onthemetabolism
ofBP by rat livermicrosomes and on the bindingof
BP to macromolecules in vitro. They found that
Mn2" stimulated the metabolism of BP in vitro,
while Cu2, Zn,2+ Pb2+, Ni2+, Cr3+, Fe3+, Mg2+
allinhibited BPmetabolism(withfallingefficiency).
Cu2+, Cr3+, Zn2,+ Cd2+, Mn2+, and Ni2+ all
inhibited thebindingofBPtomacromolecules (with
falling efficiency). Mg2+ did not affect binding,
while Fe3+ increased the binding up to 10 ,umole
Fe3+/assay. At higherconcentrations, Fe3+ inhibited
BP binding.
Conclusions
BP, nitrosamines and asbestos are all regarded
as human carcinogens. They all appear in combina-
tion with metals in human exposure media. As far
as interactions between BP and metal oxides are
concerned a considerable body of knowledge is
available, demonstrating that Fe2O3, MgO, TiO2
and possibly other dusts strongly potentiated the
carcinogenic activity of BP when instilled intra-
tracheally in combination. The reason for this is
probably an increased retention time for BP in the
respiratory tract when BP is associated with car-
rier dust. For nitrosamines, results suggest that
tumor localization can be significantly changed and
the latency time shortened by metal oxide expo-
sures. The underlying mechanism remains unclear.
For asbestos carcinogenesis, an effect of asbestos-
associated metal ions in relation to the carcinogenic
process has been suggested, but furtherresearch is
neededbeforethe plausibility ofthishypothesis can
be evaluated.
Concluding Remarks
It was stressed that human exposures often
involve complex mixtures of potentially hazardous
metal compounds. Such mixtures occur both in the
occupational and general environment, but so far,
only few of the important combinations existing
have been investigated in experimental systems.
Interactions that have been demonstrated are sum-
Environmental Health Perspectivesmarized after each section in the main text of this
review and this section will only deal with a few
aspects of general interest. In several cases, the
mechanism behind enhancement or inhibition of
carcinogenesis is unclear, but a few examples of
interactions taking place at different levels in the
metabolism ofcarcinogens may be mentioned. The
followingcategories ofinteraction can be identified:
(1) Change in absorption and retention ofcarcin-
ogens (e.g., BP-metal oxide particle interactions).
(2) Effect on biochemical metabolism (e.g., inhi-
bition ofmicrosomal drug metabolizing enzymes by
metals such as Cd, Pb, etc.).
(3) Change ofvalency state ofa metal carcinogen
(redox effects). Examples are the role of oxidizing
and reducing agents on the mutagenic activity of
chromium compounds, the effect of Mn° on Ni3S2
carcinogenesis and the antioxidant effect of sele-
nium reducing the carcinogenic effect of several
organic carcinogens.
(4) Effects of metals and other agents on DNA
synthesis and repair (e.g., the combined effect of
UV light and arsenic compounds).
(5) Modification ofhormonal regulation (e.g., the
protective effects of zinc against ICSH-induced
Leydigomas after cadmium injection).
Itis evidently useful, particularly when tryingto
relate experimental observations to human expo-
sure situations, to have an indication ofthe mecha-
nism through which interactions take place. Fur-
therresearch aimingattheidentification ofadditional
interactions ofthe type listed would, therefore, be
ofgreat value. Experiments utilizingestablished in
vitro systems such as the Ames test, induction of
high sister chromatid exchange rate in cultured
lymphocytes, and either direct or virus-mediated
cell transformation, as well as neoplastic transfor-
mation in tissue culture may be used to investigate
possible interactions as well as long-term tests in
laboratory animals. An important area ofresearch
is the testing of complex mixtures of metal-
containing pollutants that occur in working envi-
ronments, ambient air, food or drinking water.
These assays should be related to effects of the
pure constituents (individually and in combination)
in parallel.
This report was prepared with support in part by a grant to
the Department of Community Health and Environmental
Medicine, Odense University from the Swedish Project
Coal-Health-Environment.
REFERENCES
1. Nordberg, G. F., Wester, P. O., and Brune, D. Tissue
levels of25 elements in smelter workers. Proc. Int. Symp.
on the Control of Air Pollution in the Working Environ-
ment, Liber Tryck, Stockholm, 1978, pp. 261-272.
2. Brune, D., Nordberg, G. F., and Wester, P. 0. Distribu-
tion of 23 elements in kidney, liver, and lung of a control
groupinNorthSwedenandofexposedworkersfromasmelter
and refinery. Sci. Total Environ. 16: 13 (1980).
3. Pershagen, G., Elinder, C.-G., and Bolander, A.-M. Mor-
tality in a region surrounding an arsenic emitting plant.
Environ. Health Perspect.- 19: 133 (1977).
4. Nordberg, G. F., Fowler, B. A., Friberg, L.,Jernelov, A.,
Nelson, N., Piscator, M., Sandstead, H., Vostal, J., and
Vouk, V. B. Factors influencingmetabolism and toxicity of
metals . Environ. Health Perspect. 25: 3 (1978).
5. Fischer, G. L. Trace element interactions in carcino-
genesis. In: Trace Metals in Health and Disease, N.
Karasch, Ed., Raven Press, New York, 1979, pp. 93-107.
6. Sunderman, F. W., Jr. Carcinogenicity and anticarcino-
genicity of metal compounds. In: Environmental Carcino-
genesis, P. Emmelot and E. Kriek, Eds., Elsevier/North
Holland Press, Amsterdam, 1979, pp. 165-192.
7. IARC. Monographs onthe Evaluation ofCarcinogenic Risk
of Chemicals to Man. Vol. 23, IARC, Lyon, in press.
8. Pershagen, G. Carcinogenicity ofarsenic. Environ. Health
Perspect. 40: 93 (1981).
9. Lee, A. M., and Fraumeni, J. F., Jr. Arsenic and
respiratory cancer in man: an occupational study. J.
Natl. Cancer Inst. 42: 1045 (1969).
10. Oppenheim, J. J., and Fishbein, W. N. Induction of
chromosome breaks in cultured human leukocytes by
potassium arsenite, hydroxyurea and related compounds.
Cancer Res. 25: 980 (1965).
11. Paton, G. R., and Allison, A. C. Chromosome damage in
human cell cultures induced bymetal salts. Mutat. Res. 16:
332 (1972).
12. Petres, J., Schmid-Ulrich, K, and Wolf, U. Chromosomen-
aberrationen anmenschlichen Lymphozyten bei chronischen
Arsenschaden. Dtsch. Med. Wochenschr. 2: 79 (1970).
13. Petres, J., Baron, D., and Hagedorn, M. Effects ofarsenic
cell metabolism and cell proliferation: cytogenic and bio-
chemical studies. Environ. Health Perspect. 19: 223 (1977).
14. Beckman, G., Beckman, L., and Nordenson, I. Chromo-
some aberration in workers exposed to arsenic. Environ.
Health Perspect. 19: 145 (1977).
15. Nordenson, I., Beckman, G., Beckman, L., and
Nordstrom, G. Occupational and environmental risks
in and around a smelter in Northern Sweden. Hereditas
88: 7 (1978).
16. Nishioka, H. Mutagenic activities of metal compounds in
bacteria. Mutat. Res. 31: 185 (1975).
17. Lofroth, G., and Ames, B. N. Mutagenicity of inorganic
compounds in Salmonella typhimurium: arsenic, chromium
and selenium (Abstr.). Mutat. Res. 63: 65 (1978).
18. Rossman, T. G., Stone, D., Molina, M., and Troll, W.
Absence of arsinite mutagenicity in E. coli and Chinese
hamster cells. Environ. Mutagen., in press.
19. Rossman, T. G., Meyn, M. S., and Troll, W. Effects of
arsenite on DNA repair in E. coli. Environ. Health
Perspect. 19: 229 (1977).
20. Rosen, P. Theoretical significance of arsenic as a carcino-
gen. J. Theor. Biol. 32: 425 (1971).
21. Jung, E. G., Trachsel, B., and Immich, H. Arsenic as an
inhibitor of the enzymes concerned in cellular recovery
(dark repair). Ger. Med. Mon. 14: 614 (1969).
22. Boutwell, R.K. A carcinogenicity evaluation of potassium
arsenite and arsanilic acid. J. Agr. Food Chem. 11: 381
(1963).
23. Baroni, C., van Esch, G. J., and Saffiotti, U.
Carcinogenesis tests of two inorganic arsenicals.
Arch. Environ. Health 7: 668 (1963).
August 1981 7724. Kroes, R., van Logten, M. J., Berkvens, J. M., de Vries,
T., and Esch, G. J. Study on the carcinogenicity of lead
arsenate and sodium arsenate and on the possible synergis-
tic effect ofdiethylnitrosamine. Food Cosmet. Toxicol. 12:
671 (1974).
25. Ishinishi, N. Kodama, Y., Nobutomo, K., and Hisanaga,
A. Preliminary experimental study on carcinogenicity of
arsenic trioxide in rat lung. Environ. Health Perspect. 19:
191 (1977).
26. Ivankovic, S., Eisenbrand, G., and Preussmann, R. Lung
carcinoma induction in BD rats after single intratracheal
instillation of an arsenic-containing pesticide mixture for-
merly used in vineyards. Int. J. Cancer 24: 786 (1979).
27. Schrauzer, G. N., and Ishmael, D. B. A. Effects of
selenium and of arsenic on the genesis of spontaneous
mammary tumors ininbred C3H mice. Ann. Clin. Lab. Sci.
4: 441 (1974).
28. Kanisawa, M., and Schroeder, H. A. Life term studies on
the effects of arsenic, germanium, tin, vanadium on spon-
taneous tumors in mice. Cancer Res. 17: 1192 (1967).
29. Milner, J. E. The effect of ingested arsenic on
methylcholanthrene-induced skin tumors in mice. Arch.
Environ. Health 18: 7 (1969).
30. Levander, 0. A. Metabolic interrelationships between
arsenic and selenium. Environ. Health Perspect. 19: 159
(1977).
31. Walker, G. W. R., and Bradley, A. M. Interacting effects
of sodium monohydrogenarsenate and selenocystine on
crossing over in Drosophila melanogaster. Can. J. Genet.
Cytol. 11: 677 (1969).
32. Moutschen, J., and Degraeve, N. Influence of thiol-
inhibiting substances on the effects of ethyl methane
sulphonate (EMS) on chromosomes. Experientia 21: 200
(1965).
33. gcram, R. J., and Bencko, V. A contribution to the
evaluation ofthe genetic risk ofexposure to arsenic. &esk.
Hyg. 19: 308 (1974).
34. Bencko, V. Carcinogenic, teratogenic and mutagenic ef-
fects ofarsenic. Environ. Health Perspect. 19: 179 (1977).
35. Nelson, A. A., Fitzhugh, 0. H., and Calvery, H. 0. Liver
tumors following cirrhosis caused by selenium in rats.
Cancer Res. 3: 230 (1943).
36. Tscherkes, L. A., Aptekar, S. G., and Volgarev, M. N.
Hepatic tumors induced by selenium. Byull. Eksp. Biol.
Med. 53: 78 (1961).
37. Tinsley, I. J., Harr, J. R., Bone, J. F., Weswig, P. H., and
Yamamoto, R. S. Selenium toxicity in rats. I. Growth and
longevity. In: Selenium in Biomedicine, 0. H. Muth, Ed.,
AVI, Westport, 1967.
38. Harr, J. R., Bone, J. F., Tinsley, I. J., Weswig, P. H., and
Yamamoto, R. S. Selenium toxicity in rats. II. Histopa-
thology. In: Selenium in Biomedicine, 0. H. Muth, Ed.,
AVI, Westport, 1967.
39. IARC, Monographs on the Evaluation ofthe Carcinogenic
Risk of Chemicals to Man, Vol. 9, IARC, Lyon, 1975, pp.
250-256.
40. Schrauzer, G. N., White, D. A., and Schneider, C.
Inhibition ofthe genesis ofspontaneous mammary tumors
inC3Hmice:effectsofseleniumandofselenium-antagonistic
elements and their possible role in human breast cancer.
Bioinorg. Chem. 6: 265 (1976).
41. Harr, J. R., Exon, J. H., Whanger, P. D., and Weswig, P.
H. Effect of dietary selenium on N-2-fluorenylacetamide
(FAA) induced cancer in vitamin E supplemented selenium
depleted rats. Clin. Toxicol. 5: 187 (1972).
42. Griffin, A. C., andJacobs, M. M. Effects ofselenium on azo
dye hepatocarcinogenesis. Cancer Lett. 3: 177 (1977).
43. Jacobs, M. M., Jansson, B., and Griffin, A. C. Inhibitory
effects of selenium on 1,2-dimethylhydrazine and methyl-
azoxymethanolacetate induction of colon tumors. Cancer
Lett. 2: 133 (1977).
44. Clayton, C. C., and Baumann, C. A. Diet and azo dye
tumors: effect of diet during a period when the dye is not
fed. Cancer Res. 9: 575 (1949).
45. Shamberger, R. J. Relationship of selenium to cancer. I.
Inhibitory effect of selenium on carcinogenesis. J. Natl.
Cancer Inst. 44: 931 (1970).
46. Shamberger, R. J., and Rudolph, G. Protection against
cocarcinogenesisbyantioxidants. Experientia22: 116(1966).
47. Riley, J. F. Mast cells, cocarcinogenesis and anti-
carcinogenesis in the skin of mice. Experientia 24:
1237 (1968).
48. Exon, J. H., Koller, L. D., and Elliott, S. C. Effect of
Dietary selenium on tumor induction by an oncogenic
virus. Clin. Toxicol. 9: 273 (1976).
49. Broghamer, W. L., Jr., McConnell, K. P., and Bloteky, A.
J. Relationship between serum selenium levels and pa-
tients with carcinoma. Cancer 37: 1384 (1976).
50. Broghamer, W. L., Jr., McConnell, K. P. Grimaldi, M.,
and Bloteky, A. J. Serum selenium and reticuloendothelial
tumors. Cancer 41: 1462 (1978).
51. Shamberger, R. J., Rukovena, E., Longfield, A. K.,
Tytko, S. A., Deodhar, S., and Willis, C. E. Antioxidants
and cancer. I. Selenium in the blood ofnormals and cancer
patients. J. Natl. Cancer Inst. 50: 863 (1973).
52. McConnell, K. P., Broghamer, W. L., Jr., Blotcky, A. J.,
and Hurt, 0. J. Selenium levels in human blood and tissues
in health and disease. J. Nutr. 105: 1026 (1975).
53. Shamberger, R. J., and Willis, C. E. Selenium distribution
and human cancer mortality. CRC Crit. Rev. Clin. Lab.
Sci. 2: 211 (1971).
54. Shamberger, R. J., Tytko, S. A., and Willis, C. E.
Antioxidants and cancer. VI. Selenium and age-adjusted
human cancer mortality. Arch. Environ. Health 31: 231
(1976).
55. Schrauzer, G. N., White, D. A., and Schneider, C. J.
Cancer mortality correlation studies. III: Statistical asso-
ciations with dietary selenium intakes. Bioinorg. Chem. 7:
23 (1977).
56. Nakamuro, K., Yoshikawa, K., Sayato, Y., Kurata, H.,
Tonomura, M., and Tonomura, A. Studies on selenium-
related compounds. V. Cytogenetic effect and reactivity
with DNA. Mutat. Res. 40: 177 (1976).
57. Noda, M., Takano, T., and Sakurai, H. Mutagenic activity
of selenium compounds. Mutat. Res. 66: 175 (1979).
58. Lo, L. W., Koropatnick, J., and Stich, H. F. The
mutagenicity and cytotoxicity of selenite, "activated"
selenite, and selenate for normal and DNA repair-
deficient human fibroblasts. Mutat. Res. 49: 305
(1978).
59. Ray, J. H., and Altenburg, L. C. Sister-chromatid ex-
change induction by sodium selenite: dependence on the
presence ofred blood cells or red blood cell lysate. Mutat.
Res. 54: 343 (1978).
60. Jacobs, M. M., Matney, T. S., and Griffin, A. C. Inhibitory
effects of selenium on the mutagenicity of 2-acetylamino-
fluorene (AAF) and AAF metabolites. Cancer Lett. 2: 319
(1977).
61. Shamberger, R. J., Baughman, F. F., Kalchert, S. L.,
Willis, C. E., and Hoffman, G. C. Carcinogen-induced
chromosomal breakage decreased by antioxidants. Proc.
Natl. Acad. Sci. (U.S.) 70: 1461 (1973).
62. Sunderman, F. W., Jr. Metal carcinogenesis. In: Toxicol-
ogy ofTrace Elements, R. A. Goyer and M. A. Mehlman,
Eds., John Wiley and Sons, New York, 1977.
63. Petering, H. G., Buskirk, H. H., and Crim,J. A. The effect
78 Environmental Health Perspectivesofdietary mineral supplements ofthe rat on the antitumor
activity of 3-ethoxy-2-oxobutyraldehyde-bisthiocarbazone.
Cancer Res. 27: 1115 (1967).
64. Duncan, J. R., Dreosti, I. E., and Albrecht, C. F. Zinc
intake and growth of a transplanted hepatoma induced by
3-methyl-4-dimethylaminoazobenzene inrats. J. Natl. Can-
cer Inst. 53: 277 (1974).
65. McQuitty, J. T., Jr., DeWys, W. D., Monaco, L., Strain,
W. H., Rob, C. G., Apgar, J., and Pories, W. J. Inhibition
oftumor growth bydietary zinc deficiency. Cancer Res. 30:
1387 (1970).
66. DeWys, W., Pories, W. J., Richter, M. C., and Strain, W.
H. Inhibition of Walker 256 carcinosarcoma growth by
dietary zinc deficiency. Proc. Soc. Exptl. Biol. Med. 135: 17
(1970).
67. DeWys, W., and Pories, W. Inhibition of a spectrum of
animal tumors by dietary zinc deficiency. J. Natl. Cancer
Inst. 48: 375 (1972).
68. Barr, D. H., and Harris, J. W. Growth of the P388
leukemia as an ascites tumor in zinc-deficient mice. Proc.
Soc. Exptl. Biol. Med. 144: 284 (1973).
69. Phillips, J. L., and Sheridan, P. J. Effect of zinc adminis-
tration on the growth of L1210 and BW5147 tumors in
mice. J. Natl. Cancer Inst. 57: 361 (1976).
70. Fong, L. Y. Y., Sivak, A., and Newberne, P. M. Zinc-
deficiency and methylbenzylnitrosamine-induced esopha-
geal cancer in rats. J. Natl. Cancer Inst. 61: 145 (1978).
71. Duncan, J. R., and Dreosti, I. E. Zinc intake, neoplastic
DNA synthesis and chemical carcinogenesis in rats and
mice. J. Natl. Cancer Inst. 55: 195 (1975).
72. Wallenius, K., Mathur, A., and Abdulla, M. Effect of
different levels ofdietary zinc on development ofchemically
induced oral cancer in rats. Int. J. Oral Surg. 8: 56 (1979).
73. Poswillo, D. E., and Cohen, B. Inhibition ofcarcinogenesis
by dietary zinc. Nature 231: 447 (1971).
74. Edwards, M. B. Chemical carcinogenesis in the cheek
pouch of Syrian hamsters receiving supplementary zinc.
Arch. Oral Biol. 21: 133 (1976).
75. Ciaparelli, L., Retief, D. H., and Fatti, L. P. The effect of
zinc on 9,10-dimethyl-1,2-benzanthracene (DMBA) induced
salivary gland tumors in the albino rat-a preliminary
study. S. Afr. J. Med. Sci. 37: 85 (1972).
76. Stocks, P., and Davies, R. I. Zinc and copper content of
soils associated with the incidence ofcancer ofthe stomach
and other organs. Brit. J. Cancer 18: 14 (1964).
77. Hiryama, T. Quoted in S. Afr. Cancer Bull. 6: 114 (1962).
78. Schrauzer, G. N., White, D. A., and Schneider, C. J.
Cancermortality correlation studies. IV: Associations with
dietary intakes and blood levels ofcertain trace elements,
notably Se-antagonists. Bioinorg. Chem. 7: 35 (1977).
79. Kubota, J., Lazar, V. A., and Losee, F. Copper, zinc,
cadmium and lead in human blood from 19 locations in the
United States. Arch. Environ. Health 16: 788 (1968).
80. Sundennan, F. W., Jr. Recent research on nickel carcino-
genesis. Environ. Health Perspect. 40: 131 (1981).
81. National Academy of Sciences: Nickel carcinogenesis. In:
Nickel. Committee on Medical and Biological Effects of
Environmental Pollutants. Division of Medical Sciences.
National Research Council, NAS, Washington, D.C., 1975.
82. Maenza, R. M., Pradhan, A. M., and Sunderman, F. W.,
Jr. Rapid induction of sarcomas in rats by combination of
nickel sulfide and 3,4-benzpyrene. Cancer Res. 31: 2067
(1971).
83. Kasprzak, K. S., Marchow, L., and Breborowicz, J.
Pathological reactions in rat lungs following intratracheal
injection of nickel-subsulfide and 3,4-benzpyrene. Res.
Commun. Chem. Pathol. Pharmacol. 6: 237 (1973).
84. Toda, M. Experimental studies ofoccupational lungcancer.
Bull. Tokyo Med. Dent. Univ. 9: 440 (1963).
85. Sunderman, F. W., Jr. Inhibition of induction of
benzpyrene hydroxylase by nickel carbonyl. Cancer
Res. 27: 950 (1967).
86. Sunderman, F. W., Jr. Nickel carbonyl inhibition of
phenobarbital induction ofhepatic cytochrome P-450. Can-
cer Res. 28: 465 (1968).
87. Sunderman, F. W., Jr., and Roszel, N. 0. Effect ofnickel
carbonyl upon the detoxification and mobilization of
3,4-benzpyrene. Am. J. Clin. Pathol. 49: 240 (1968).
88. Beach, D. J., and Sunderman, F. W., Jr., Nickel carbonyl
inhibition of 14C-orotic acid incorporation into rat liver
RNA. Proc. Soc. Exptl. Biol. Med. 131: 321 (1969).
89. Beach, D. J., and Sunderman, F. W., Jr. Nickel carbonyl
inhibition ofRNA synthesis by a chromatin-RNA complex
from hepatic nuclei. Cancer Res. 30: 48 (1970).
90. Sunderman, F. W., Jr., Lau, T. J., and Cralley, L. J.
Inhibitory effect ofmanganese upon muscle tumorigenesis
by nickel subsulfide. Cancer Res. 34: 92 (1974).
91. Sunderman, F. W., Jr., Kasprzak, K. S., Lau, T. J.,
Minghetti, P. P., Maenza, R. M., Becker, N., Onkelinx,
C., and Goldblatt, P. J. Effects of manganese on
carcinogenicity and metabolism of nickel subsulfide. Can-
cer Res. 36: 1790 (1976).
92. Costa, M., Nye, J., and Sunderman, F. W., Jr. Morpholog-
icaltransformation ofSyrian hamster fetal cells induced by
nickel compounds. Ann. Clin. Lab. Sci. 8: 502 (1978).
93. Kreyberg, L. Lung cancer in workers in a nickel refinery.
Brit. J. Ind. Med. 35: 109 (1978).
94. Lessard, R., Reed, D., Maheux, B., and Lambert, J. Lung
cancer in New Caledonia, a nickel smelting island. J.
Occup. Med. 20: 815 (1978).
95. Doll, R., Morgan, L. G., and Speizel, F. E. Cancer of the
lung and nasal sinuses in nickel workers. Brit. J. Cancer
24: 623 (1970).
96. Wehner, A. P., Busch, R. H., Olson, R. J., and Craig, D.
K. Chronic inhalation of nickel oxide and cigarette smoke
by hamsters. Am. Ind. Hyg. Assoc. J. 36: 801 (1975).
97. Dingwall-Fordyce, I., and Lan, R. E. A follow-up study of
lead workers. Brit. J. Ind. Med. 20: 313 (1963).
98. Hammond, P. B., Aronson, A. L., Chisholm, J. J., Jr.,
Falk, J. L., Keenan, R. G., and Sandstead, H. H. Airborne
lead in perspective. National Academy of Sciences, Wash-
ington, D.C., 1972.
99. Cooper, W. C., and Gaffey, W. R. Mortality of lead
workers. J. Occup. Med. 17: 100 (1975).
100. Kang, H. K., Infante, P. F., and Carra, J. S. Occupational
lead exposure and cancer. Science 207: 935 (1980).
101. Cooper, W. C. Cancer mortality patterns in the lead
industry. Ann. N.Y. Acad. Sci. 271: 150 (1976).
102. Kobayashi, N., and Okamoto, T. Effects of lead oxide on
the induction of lung tumors in Syrian hamsters. J. Natl.
Cancer Inst. 52: 1605 (1974).
103. Beek, B., and Obe, G. Effect of lead acetate on human
leukocyte chromosomes in vitro. Experientia 30: 1006
(1974).
104. Skreb, Y., and Habazin-Novak, V. Lead induced
modifications of the response to x-rays in human cells
in culture. Stud. Biophys. 63: 97 (1977).
105. Deknudt, G., Colle, A., and Gerber, G. B. Chromosomal
abnormalities in lymphocytes from monkeys poisoned with
lead. Mutat. Res. 45: 77 (1977).
106. Bauchinger, M., Schniid, E., and Schmidt, D. Cnromo-
somenanalyse bei Verkehrspolizisten mit erhohter Bleilast.
Mutat. Res. 16: 407 (1972).
107. Bauchinger, M., Dresp, J., Schmid, E., Englert, N., and
Krause, C. Chromosome analysis ofchildren after ecologi-
cal lead exposure. Mutat. Res. 56: 75 (1977).
August 1981 79108. Schmid, E., Bauchinger, M., Pietruck, S., and Hall, G. Die
cytogenetische Wirkung von Blei in menschlichen peripheren
Lymphocyten in vitro und in vivo. Mutat. Res. 16: 401
(1972).
109. Bauchinger, M., and Schmid, E. Chromosomenanalysen in
Zeilkulturen des Chinesischen Hamsters nach Applikation
von Bleiacetat. Mutat. Res. 14: 95 (1972).
110. Deknudt, G., and Leonard, A. Cytogenetic investigations
on leukocytes ofworkers from a cadmium plant. Environ.
Physiol. Biochem. 5: 319 (1975).
111. Deknudt, G., Leonard, A., and Ivanov, B. Chromosome
aberrations observed in male workers occupationally ex-
posed to lead. Environ. Physiol. Biochem. 3: 132 (1973).
112. Bauchinger, M., Schmid, E., Einbrodt, H. J., and Dresp,
J. Chromosome aberrations in lymphocytes after occupa-
tional exposure to lead and cadmium. Mutat. Res. 40: 57
(1976).
113. Nordenson, I., Beckman, G., Beckman, L., and Nord-
strom, S. Occupational and environmental risks in and
around a smelter in northern Sweden. IV. Chromosomal
aberrations in workers exposed to lead. Hereditas 88: 263
(1978).
114. Tsuchiya, K. Lead. In: Handbook on the Toxicology of
Metals. L. Friberg, G. F. Nordberg, and V. B. Vouk,
Eds., Elsevier, Amsterdam, 1979, pp. 451-484.
115. Norseth, T. Carcinogenicity ofchromium. Environ. Health
Perspect. 40: 121 (1981).
116. Langard, S., and Norseth, T. Chromium. In: Handbook on
the Toxicology ofMetals, L. Friberg, G. F. Nordberg, and
V. B. Vouk, Eds., Elsevier, Amsterdam, 1979, pp. 384-397.
117. Kazantzis, G., and Lilly, L. Mutagenic and carcinogenic
effects of metals. In: Handbook on the Toxicology of
Metals, L. Friberg, G. F. Nordberg, and B. V. Vouk,
Eds., Elsevier, Amsterdam, 1979, pp. 237-272.
118. Tsuda, H., and Kato, K. Potassium dichromate-induced
chromosome abserrations and its control with sodium
sulfite in hamster embryonic cells in vitro. Gann 67: 469
(1976).
119. Tsuda, H., and Kato, K. Chromosomal aberrations and
morphological transformation in hamster embryonic cells
treated with potassium dichromate in vitro. Mutat. Res.
46: 87 (1977).
120. Petrilli, F. L., and DeFlora, S. Metabolic deactivation of
hexavalent chromium mutagenicity. Mutat. Res. 54: 139
(1978).
121. Gruber, J. E., and Jennette, K. W. Metabolism of the
carcinogen chromate by rat liver microsomes. Biochem.
Biophys. Res. Commun. 82: 700 (1978).
122. Petrilli, F. L., and DeFlora, S. Oxidation of inactive
trivalent chromium to the mutagenic hexavalent form.
Mutat. Res. 58: 167 (1978).
123. Nakamuro, K., Yoshikawa, K., Sayato, Y., and Kurata, H.
Comparative studies of chromosomal aberration and
mutagenicity oftrivalent and hexavalent chromium. Mutat.
Res. 58: 175 (1978).
124. Lane, B. P., and Mass, M. J. Carcinogenicity and
cocarcinogenicity of chromium carbonyl in heterotopic
tracheal grafts. Cancer Res. 37: 1476 (1977).
125. Piscator, M. Role of cadmium in carcinogenesis. Environ.
Health Perspect. 40: 107 (1981).
126. Gunn, S. A., Gould, T. C., and Anderson, W. A. D.
Cadmium induced interstitial cell tumors in rats and mice
and their prevention by zinc. J. Natl. Cancer Inst. 31: 745
(1963).
127. Gunn, S. A., Gould, T. C., and Anderson, W. A. D. Effect
of zinc on cancerogenesis by cadmium. Proc. Soc. Exptl.
Biol. Med. 115: 653 (1964).
128. Kar, A. B., Das, R. P., and Mukerji, B. Prevention of
cadmium induced changes in the gonads ofrat by zinc and
selenium. A study in antagonism between metals in the
biological system. Proc. Natl. Inst. Sci. India, B, Biol. Sci.
26: 40 (1960)
129. Gunn, S. A., Gould, T. C., and Anderson, W. A. D.
Mechanisms of zinc, cysteine and selenium protection
against cadmium-induced vascular injury to mouse testis.
J. Reprod. Fertil. 15: 65 (1968).
130. Gabbiani, G., Baic, D., and Deziel, C. Studies on tolerance
and ionic antagonism for cadmium or mercury. Can. J.
Physiol. Pharmacol. 45: 443 (1967).
131. Ito, T., and Sawauchi, K. Inhibitory effects on cadmium-
induced testicular damage by pretreatment with smaller
cadmium dose. Okajimas Folia Anat. Japan 42: 107 (1966).
132. Nordberg, G. F. Effects of acute and chronic cadmium
exposure on the testicles ofmice. Environ. Physiol. 1: 171
(1971).
133. Nordberg, G. F. Cadmium metabolism and toxicity. Envi-
ron. Physiol. Biochem. 2: 7 (1972).
134. O'Riordan, M. L., Hughes, E. G., and Evans, H. J.
Chromosome studies on blood lymphocytes ofmen occupa-
tionally exposed to cadmium. Mutat. Res. 58: 305 (1978).
135. Unger, M., and Clausen, J. Liver cytochrome P-450
activity after intraperitoneal administration of cadmium
salts in the mouse. Environ. Physiol. Biochem. 3: 236
(1973).
136. Schnell, R. C., Means, J. R., Roberts, S. A., and Pence, D.
H. Studies on cadmium-induced inhibition of hepatic
microsomal drug biotransformation in the rat. Environ.
Health Perspect. 28: 273 (1979).
137. Saffioti, U., Cefis, F., and Kolb, L. H. A method for the
experimental induction ofbronchogenic carcinoma. Cancer
Res. 28: 104 (1968).
138. Feron, V. J. Respiratory tract tumors in hamsters after
intratracheal instillations ofbenzo(a)pyrene alone and with
furfural. Cancer Res. 32: 28 (1972).
139. Feron, V. J., DeJong, D., and Emmelot, P. Dose-response
correlation for the induction ofrespiratory tract tumors in
Syrian golden hamsters by intratracheal instillations of
benzo(a)pyrene. Eur. J. Cancer 9: 387 (1973).
140. Saffiotti, U., Montesano, R., Sellakumar, A. R., Cefis, F.,
and Kaufman, D. G. Respiratory tract carcinogenesis in
hamsters induced by different numbers ofadministrations
of benzo(a)pyrene and ferric oxide. Cancer Res. 32: 1073
(1972).
141. Saffiotti, U., Montesano, R., Sellakumar, A. R., and
Kaufman, D. G. Respiratory tract carcinogenesis induced
in hamsters by different dose levels ofbenzo(a)pyrene and
ferric oxide. J. Natl. Cancer Inst. 49: 1199 (1972).
142. Henry, M. C., Port, C. D., and Kaufman, D. G. Impor-
tance ofphysical properties ofbenzo(a)pyrene-ferric oxide
mixtures in lung tumor induction. Cancer Res. 35: 207
(1975).
143. Saffiotti, U. Experimental respiratory tract carcinogenesis
and its relation to inhalation exposures. In: Inhalation
Carcinogenesis. M. G. Hanna, Jr., D. Nettesheim, and J.
R. Gilbert, Eds., U.S. Atomic Energy Commission, Wash-
ington, D.C., 1970.
144. Stenback, F., Sellakumar, A., and Shubik, P. Magnesium
oxide as carrier dust in benzo(a)pyrene-induced lung
carcinogenesis in Syrian hamsters. J. Natl. Cancer Inst.
54: 861 (1975).
145. Stenback, F., Rowland, J., and Sellakumar, A.
Carcinogenicity of benzo(a)pyrene and dusts in the
hamster lung (instilled intratracheally with titanium
oxide, aluminum oxide, carbon and ferric oxide).
Oncology 33: 29 (1976).
146. Montesano, R., Saffiotti, U., Ferrero, A., and Kaufman,
80 Environmental Health PerspectivesD. G. Synergistic effects of benzo(a)pyrene and diethyl-
nitrosamine on respiratory carcinogenesis in hamsters. J.
Natl. Cancer Inst. 53: 1395 (1974).
147. Stenback, F. G., Ferrero, A., and Shubik, P. Synergistic
effectsofdiethylnitrosamine anddifferentdustsonrespiratory
carcinogenesis in hamsters. Cancer Res. 33: 2209 (1973).
148. Nettesheim, P., Creasia, D. A., and Mitchell, T. J.
Carcinogenic and cocarcinogenic effects of inhaled syn-
thetic smogand ferric oxide particles. J. Natl. Cancer Inst.
55: 159 (1975).
149. Ivankovic, S., Zeller, W. J., and Schmahl, D. Steigerung
der Carcinogenen Wirkung von Athyl-nitrosoharnstoff
durch Schwermetalle. Naturwiss. 59: 369 (1972).
150. Zeller, W. J., and Ivankovic, S. Steigerung der toxischen
WirkungvonAlkylnitrosoharnstoffen durch Schwermetalle.
Naturwiss. 59: 82 (1972).
151. Habs, M. Untersuchung des Einflusses der Schwermetall-
salze Zinkehlorid, Eisen(II)chlorid und Mangan(II)chlorid
auf der cancerogene Wirkung von Athylnitrosoharnstoff.
Ph.D. Thesis, University of Heidelberg, 1973.
152. Zeller, W. J. Untersuchungen zum Einfluss von Kupfer
und Kobaltionen auf die Karzinogenese durch Diathyl-
nitrosaniin (DANA) bei Wistar-Ratten. Arch. Geschwulst-
forsch. 45: 634 (1975).
153. Cralley, L. J. Electromotive phenomenon in metal and
mineral particulate exposures: relevance to exposure to
asbestos and occurrence of cancer. Am. Ind. Hyg. Assoc.
J. 32: 653 (1971).
154. Thomson, R., Webster, I., and Kilroe-Smith, T. A. The
metabolism ofbenzo(a)pyrene in rat liver microsomes: the
effect of asbestos-associated metal ions and pH. Environ.
Res. 7: 149 (1974).
155. Thomson, R., Kilroe-Smith, T. A., and Webster, I. The
effect of asbestos-associated metal ions on the binding of
benzo(a)pyrene to macromolecules in vitro. Environ. Res.
15: 309 (1978).
August 1981 81